Skip to main content
Top
Published in: Journal of General Internal Medicine 12/2007

01-12-2007 | Original Article

Reasons for Not Intensifying Medications: Differentiating “Clinical Inertia” from Appropriate Care

Authors: Monika M. Safford, MD, Richard Shewchuk, PhD, Haiyan Qu, PhD, Jessica H. Williams, MPH, Carlos A. Estrada, MD, MS, Fernando Ovalle, MD, Jeroan J. Allison, MD, MSc

Published in: Journal of General Internal Medicine | Issue 12/2007

Login to get access

Abstract

Background

“Clinical inertia” has been defined as inaction by physicians caring for patients with uncontrolled risk factors such as blood pressure. Some have proposed that it accounts for up to 80% of cardiovascular events, potentially an important quality problem. However, reasons for so-called clinical inertia are poorly understood.

Objective

To derive an empiric conceptual model of clinical inertia as a subset of all clinical inactions from the physician perspective.

Methods

We used Nominal Group panels of practicing physicians to identify reasons why they do not intensify medications when seeing an established patient with uncontrolled blood pressure.

Measurements and Main Results

We stopped at 2 groups (N = 6 and 7, respectively) because of the high degree of agreement on reasons for not intensifying, indicating saturation. A third group of clinicians (N = 9) independently sorted the reasons generated by the Nominal Groups. Using multidimensional scaling and hierarchical cluster analysis, we translated the sorting results into a cognitive map that represents an empirically derived model of clinical inaction from the physician’s perspective. The model shows that much inaction may in fact be clinically appropriate care.

Conclusions/Recommendations

Many reasons offered by physicians for not intensifying medications suggest that low rates of intensification do not necessarily reflect poor quality of care. The empirically derived model of clinical inaction can be used as a guide to construct performance measures for monitoring clinical inertia that better focus on true quality problems.
Literature
1.
go back to reference Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339(27):1957–63.PubMedCrossRef Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339(27):1957–63.PubMedCrossRef
2.
go back to reference Borzecki AM, Wong AT, Hickey EC, Ash AS, Berlowitz DR. Hypertension control: how well are we doing? Arch Intern Med. 2003;163(22):2705–11.PubMedCrossRef Borzecki AM, Wong AT, Hickey EC, Ash AS, Berlowitz DR. Hypertension control: how well are we doing? Arch Intern Med. 2003;163(22):2705–11.PubMedCrossRef
3.
go back to reference Grant RW, Cagliero E, Dubey AK, et al. Clinical inertia in the management of Type 2 diabetes metabolic risk factors. Diabet Med. 2004;21(2):150–55.PubMedCrossRef Grant RW, Cagliero E, Dubey AK, et al. Clinical inertia in the management of Type 2 diabetes metabolic risk factors. Diabet Med. 2004;21(2):150–55.PubMedCrossRef
5.
go back to reference O’Connor P, Sperl-Hillen J, Johnson P, Rush W, Biltz G. Clinical inertia and outpatient medical errors. In: Advances in Patient Safety: From Research to Implementation, Volume 2: Concepts and Methodology. Vol 2 (of 4). Rockville, MD: Agency for Healthcare Research and Quality; 2005:293–308. O’Connor P, Sperl-Hillen J, Johnson P, Rush W, Biltz G. Clinical inertia and outpatient medical errors. In: Advances in Patient Safety: From Research to Implementation, Volume 2: Concepts and Methodology. Vol 2 (of 4). Rockville, MD: Agency for Healthcare Research and Quality; 2005:293–308.
6.
go back to reference O’Connor PJ. Overcome clinical inertia to control systolic blood pressure. Arch Intern Med. 2003;163(22):2677–78.PubMedCrossRef O’Connor PJ. Overcome clinical inertia to control systolic blood pressure. Arch Intern Med. 2003;163(22):2677–78.PubMedCrossRef
7.
go back to reference Wright JT, Jr., Dunn JK, Cutler JA, et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA. 2005;293(13):1595–608.PubMedCrossRef Wright JT, Jr., Dunn JK, Cutler JA, et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA. 2005;293(13):1595–608.PubMedCrossRef
8.
go back to reference Rodondi N, Peng T, Karter AJ, et al. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med. 2006;144(7):475–84.PubMed Rodondi N, Peng T, Karter AJ, et al. Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med. 2006;144(7):475–84.PubMed
9.
go back to reference O’Connor P. Commentary—improving diabetes care by combating clinical inertia. Health Serv Res. 2005;40(6 Pt 1):1854–61.PubMedCrossRef O’Connor P. Commentary—improving diabetes care by combating clinical inertia. Health Serv Res. 2005;40(6 Pt 1):1854–61.PubMedCrossRef
10.
go back to reference Shewchuk R, O’Connor SJ. Using cognitive concept mapping to understand what health care means to the elderly: an illustrative approach for planning and marketing. Health Market Q. 2002;20(2):69–88.CrossRef Shewchuk R, O’Connor SJ. Using cognitive concept mapping to understand what health care means to the elderly: an illustrative approach for planning and marketing. Health Market Q. 2002;20(2):69–88.CrossRef
11.
go back to reference Levine DA, Saag KG, Casebeer LL, Colon-Emeric C, Lyles KW, Shewchuk RM. Using a modified nominal group technique to elicit director of nursing input for an osteoporosis intervention. Journal of the American Medical Directors Association 2006;7(7):420–5.PubMedCrossRef Levine DA, Saag KG, Casebeer LL, Colon-Emeric C, Lyles KW, Shewchuk RM. Using a modified nominal group technique to elicit director of nursing input for an osteoporosis intervention. Journal of the American Medical Directors Association 2006;7(7):420–5.PubMedCrossRef
12.
go back to reference Schiffman S, Reynolds M, Young F. Introduction to Multidimensional Scaling. New York: Academic Press; 1981. Schiffman S, Reynolds M, Young F. Introduction to Multidimensional Scaling. New York: Academic Press; 1981.
13.
go back to reference Aldenderfer M, Blashfield R. Cluster Analysis. Beverly Hills, CA: Sage Publications; 1984. Aldenderfer M, Blashfield R. Cluster Analysis. Beverly Hills, CA: Sage Publications; 1984.
14.
go back to reference Kruskall J, Wish M. Multi-Dimensional Scaling. Newbury Park, NJ: Sage Publications; 1990. Kruskall J, Wish M. Multi-Dimensional Scaling. Newbury Park, NJ: Sage Publications; 1990.
15.
go back to reference Speece D. Methodological issues in cluster analysis: how clusters become real. In: Learning disabilities: Theoretical research issues. Hillsdale, NJ: Erlbaum; 1990:210–213. Speece D. Methodological issues in cluster analysis: how clusters become real. In: Learning disabilities: Theoretical research issues. Hillsdale, NJ: Erlbaum; 1990:210–213.
16.
go back to reference Joseph F, Hair J, Anderson RE, Tatham RL, Black WC. Multivariate Data Analysis. 5th ed. Upper Saddle River, NJ: Prentice-Hall, Inc.; 1998. Joseph F, Hair J, Anderson RE, Tatham RL, Black WC. Multivariate Data Analysis. 5th ed. Upper Saddle River, NJ: Prentice-Hall, Inc.; 1998.
17.
go back to reference Pickering TG. White coat hypertension: time for action. Circulation. 1998;98(18):1834–36.PubMed Pickering TG. White coat hypertension: time for action. Circulation. 1998;98(18):1834–36.PubMed
18.
go back to reference Kerr EA, Smith DM, Hogan MM, et al. Building a better quality measure: are some patients with ‘poor quality’ actually getting good care? Med Care. 2003;41(10):1173–82.PubMedCrossRef Kerr EA, Smith DM, Hogan MM, et al. Building a better quality measure: are some patients with ‘poor quality’ actually getting good care? Med Care. 2003;41(10):1173–82.PubMedCrossRef
19.
go back to reference Goodwin JS. Embracing complexity: a consideration of hypertension in the very old. J Gerontol Ser A Biol Sci Med Sci. 2003;58(7):653–8. Goodwin JS. Embracing complexity: a consideration of hypertension in the very old. J Gerontol Ser A Biol Sci Med Sci. 2003;58(7):653–8.
20.
go back to reference Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716–24.PubMedCrossRef Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716–24.PubMedCrossRef
21.
go back to reference Safford MM, Allison JJ, Kiefe CI. Patient complexity: more than comorbidity. The vector model of complexity. J Gen Intern Med. 2007;22(s9). Safford MM, Allison JJ, Kiefe CI. Patient complexity: more than comorbidity. The vector model of complexity. J Gen Intern Med. 2007;22(s9).
23.
go back to reference Casalino LP, Alexander GC, Jin L, Konetzka RT. General internists’ views on pay-for-performance and public reporting of quality scores: a national survey. Health Aff (Millwood). 2007;26(2):492–9.CrossRef Casalino LP, Alexander GC, Jin L, Konetzka RT. General internists’ views on pay-for-performance and public reporting of quality scores: a national survey. Health Aff (Millwood). 2007;26(2):492–9.CrossRef
Metadata
Title
Reasons for Not Intensifying Medications: Differentiating “Clinical Inertia” from Appropriate Care
Authors
Monika M. Safford, MD
Richard Shewchuk, PhD
Haiyan Qu, PhD
Jessica H. Williams, MPH
Carlos A. Estrada, MD, MS
Fernando Ovalle, MD
Jeroan J. Allison, MD, MSc
Publication date
01-12-2007
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 12/2007
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0433-8

Other articles of this Issue 12/2007

Journal of General Internal Medicine 12/2007 Go to the issue